BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33283381)

  • 1. Comparison Between Diffusion-Weighted MRI and
    Privitera L; Hales PW; Musleh L; Morris E; Sizer N; Barone G; Humphries P; Cross K; Biassoni L; Giuliani S
    J Magn Reson Imaging; 2021 May; 53(5):1486-1497. PubMed ID: 33283381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and possible value of quantitative semi-automated diffusion weighted imaging volumetry of neuroblastic tumors.
    Gassenmaier S; Tsiflikas I; Fuchs J; Grimm R; Urla C; Esser M; Maennlin S; Ebinger M; Warmann SW; Schäfer JF
    Cancer Imaging; 2020 Dec; 20(1):89. PubMed ID: 33334369
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Kitamura Y; Baba S; Isoda T; Maruoka Y; Sasaki M; Kamitani T; Koga Y; Kawakubo N; Matsuura T; Ishigami K
    Ann Nucl Med; 2021 May; 35(5):549-556. PubMed ID: 33586098
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Biassoni L; Privitera L
    Indian J Nucl Med; 2021; 36(3):293-299. PubMed ID: 34658554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different MRI sequences in lesion detection and early response evaluation of diffuse large B-cell lymphoma--a whole-body MRI and diffusion-weighted imaging study.
    Wu X; Nerisho S; Dastidar P; Ryymin P; Järvenpää R; Pertovaara H; Eskola H; Kellokumpu-Lehtinen PL
    NMR Biomed; 2013 Sep; 26(9):1186-94. PubMed ID: 23483722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted MRI and intravoxel incoherent motion model for diagnosis of pediatric solid abdominal tumors.
    Meeus EM; Zarinabad N; Manias KA; Novak J; Rose HEL; Dehghani H; Foster K; Morland B; Peet AC
    J Magn Reson Imaging; 2018 Jun; 47(6):1475-1486. PubMed ID: 29159937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3T diffusion-weighted MRI in the response assessment of colorectal liver metastases after chemotherapy: Correlation between ADC value and histological tumour regression grading.
    Donati F; Boraschi P; Pacciardi F; Cervelli R; Castagna M; Urbani L; Falaschi F; Caramella D
    Eur J Radiol; 2017 Jun; 91():57-65. PubMed ID: 28629572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of diagnostic value of I-123 MIBG and high-dose I-131 MIBG scintigraphy including incremental value of SPECT/CT over planar image in patients with malignant pheochromocytoma/paraganglioma and neuroblastoma.
    Fukuoka M; Taki J; Mochizuki T; Kinuya S
    Clin Nucl Med; 2011 Jan; 36(1):1-7. PubMed ID: 21157198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical usefulness of iodine-123-MIBG scintigraphy for patients with neuroblastoma detected by a mass screening survey.
    Hashimoto T; Koizumi K; Nishina T; Abe K
    Ann Nucl Med; 2003 Dec; 17(8):633-40. PubMed ID: 14971604
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Gassenmaier S; Bares R; Barreuther M; Flaadt T; Lang P; Schaefer JF; Tsiflikas I
    Pediatr Radiol; 2021 Jun; 51(7):1223-1230. PubMed ID: 33544193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted MRI in early chemotherapy response evaluation of patients with diffuse large B-cell lymphoma--a pilot study: comparison with 2-deoxy-2-fluoro- D-glucose-positron emission tomography/computed tomography.
    Wu X; Kellokumpu-Lehtinen PL; Pertovaara H; Korkola P; Soimakallio S; Eskola H; Dastidar P
    NMR Biomed; 2011 Dec; 24(10):1181-90. PubMed ID: 21387451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
    Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
    J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Value of Diffusion-Weighted MRI for Tumor Characterization, Differentiation and Monitoring in Pediatric Patients with Neuroblastic Tumors.
    Neubauer H; Li M; Müller VR; Pabst T; Beer M
    Rofo; 2017 Jul; 189(7):640-650. PubMed ID: 28511265
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic impact of postoperative 123I-metaiodobenzylguanidine scintigraphy: added value of SPECT/CT and semiquantification of the uptake at the surgical site.
    Gauthé M; Breton M; Jehanno N; Cellier C; Michon J; Sarnacki S; Schleiermacher G; Wartski M
    Q J Nucl Med Mol Imaging; 2020 Mar; 64(1):131-138. PubMed ID: 29409315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive value of diffusion-weighted MRI in the I-SPY 2 TRIAL.
    Li W; Newitt DC; Wilmes LJ; Jones EF; Arasu V; Gibbs J; La Yun B; Li E; Partridge SC; Kornak J; ; Esserman LJ; Hylton NM
    J Magn Reson Imaging; 2019 Dec; 50(6):1742-1753. PubMed ID: 31026118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodine-131-MIBG imaging to monitor chemotherapy response in advanced neuroblastoma: comparison with laboratory analysis.
    Maurea S; Lastoria S; Caracò C; Indolfi P; Casale F; di Tullio MT; Salvatore M
    J Nucl Med; 1994 Sep; 35(9):1429-35. PubMed ID: 8071687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Added value of SPECT/CT for correlation of MIBG scintigraphy and diagnostic CT in neuroblastoma and pheochromocytoma.
    Rozovsky K; Koplewitz BZ; Krausz Y; Revel-Vilk S; Weintraub M; Chisin R; Klein M
    AJR Am J Roentgenol; 2008 Apr; 190(4):1085-90. PubMed ID: 18356459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asphericity of tumor [
    Yadgarov M; Kailash C; Shamanskaya T; Kachanov D; Likar Y
    Pediatr Blood Cancer; 2022 Nov; 69(11):e29849. PubMed ID: 35727712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma.
    Sakane M; Tatsumi M; Kim T; Hori M; Onishi H; Nakamoto A; Eguchi H; Nagano H; Wakasa K; Hatazawa J; Tomiyama N
    Acta Radiol; 2015 Sep; 56(9):1034-41. PubMed ID: 25267921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.
    Seo Y; Gustafson WC; Dannoon SF; Nekritz EA; Lee CL; Murphy ST; VanBrocklin HF; Hernandez-Pampaloni M; Haas-Kogan DA; Weiss WA; Matthay KK
    Mol Imaging Biol; 2012 Dec; 14(6):735-42. PubMed ID: 22382618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.